Leuven Pharma Services is a financial institution; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2024 annual accounts show equity of €672k and a net result of €64k. Equity is growing by ~18% per year across the filed fiscal years. Its solvency ranks better than 32% of 6156 sector peers (fiscal year 2024). The company has been active since 2015 and the Belgian State Gazette contains no insolvency or warning signals.
Checked score
Outside the general model
Model not applicable to financial institutions
The health score weighs liquidity, leverage and margins against norms for trading and manufacturing companies. A bank, insurer or financial holding has a fundamentally different balance-sheet structure, so those ratios, and hence the score, carry no meaning here. That is why we show no financial axes either.
Credit advice for your own amount and term
Signals
Two signals. The signal on the left, the evidence on the right.
○neutral
neutral · Filed after the deadline
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 31-08-2025, 31 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 9 filingsDeviation from the deadline
2025
not confirmed
2024
31 d late
2023
26 d late
2022
4 d early
2021
2 d early
2020
26 d late
2019
30 d late
← before the deadline
after the deadline →
Financials · fiscal year 2024, abbreviated schema
Equity
€672k▲ 10.6%
2023 · €608k
2018: €264k
2019: €334k
2020: €335k
2021: €381k
2022: €490k
2023: €608k
2018 → 2024
Net result
€64k▼ 45.8%
2023 · €119k
2018: €138k
2019: €69k
2020: €1k
2021: €46k
2022: €108k
2023: €119k
2018 → 2024
Total assets
€2.08M▲ 1.2%
2023 · €2.05M
2018: €1.93M
2019: €1.95M
2020: €1.93M
2021: €1.94M
2022: €1.99M
2023: €2.05M
2018 → 2024
Solvency
32.3%▲ 2.7pp
2023 · 29.6%
2018: 13.7%
2019: 17.1%
2020: 17.3%
2021: 19.6%
2022: 24.6%
2023: 29.6%
2018 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20202021202220232024Trend
Equity€335k-€381k▲ 13.8%€490k▲ 28.5%€608k▲ 24.2%€672k▲ 10.6%
Operating result€22k-€76k▲ 248%€158k▲ 106%€170k▲ 8.0%€104k▼ 38.7%
Net result€1k-€46k▲ 4,096%€108k▲ 135%€119k▲ 9.3%€64k▼ 45.8%
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2024; 2024 is 39% below 2023.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €2.08M
Fixed assets
€1.87M▼ 0.1%
Current assets
€207k▲ 15.5%
Equity and liabilities €2.08M
Equity
€672k▲ 10.6%
Debt
€1.41M▼ 2.7%
The debt ratio falls from 70.4% to 67.7%. Equity is higher and debt is lower.
Key figures and ratios
Solvency
32.3%▲
2023 · 29.6%
ROE
9.6%▼
2023 · 19.5%
ROA
3.1%▼
2023 · 5.8%
Debt
€1.41M▼
2023 · €1.45M
Debt ≤ 1 year
€833k▲
2023 · €772k
Debt > 1 year
€568k▼
2023 · €669k
Income taxes
€25k▼
2023 · €37k
Staff costs
€158k▲
2023 · €158k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2024 against 2023
Balance sheet
Code20232024
Assets
Total assets20/58€2.05M€2.08M▲
Fixed assets21/28€1.88M€1.87M▼
Tangible fixed assets22/27€4k€1k▼
Furniture and vehicles24€4k€1k▼
Financial fixed assets28€1.87M€1.87M=
Current assets29/58€179k€207k▲
Amounts receivable within one year40/41€160k€179k▲
Other amounts receivable41€160k€179k▲
Cash at bank and in hand54/58€14k€27k▲
Deferred charges and accrued income490/1€5k€2k▼
Equity and liabilities
Total equity and liabilities10/49€2.05M€2.08M▲
Equity10/15€608k€672k▲
Contributions10/11€19k€19k=
Reserves13€590k€654k▲
Non-distributable reserves130/1€0-
Reserves not available under the articles1311€0-
Distributable reserves133€590k€654k▲
Amounts payable17/49€1.45M€1.41M▼
Amounts payable after more than one year17€669k€568k▼
Financial debts170/4€669k€568k▼
Amounts payable within one year42/48€772k€833k▲
Current portion of amounts payable after more than one year42€105k€101k▼
Financial debts43€50k€23k▼
Credit institutions430/8€50k€23k▼
Trade debts44€23k€11k▼
Suppliers440/4€23k€11k▼
Taxes, remuneration and social security45€19k€21k▲
Taxes450/3€2k€266▼
Remuneration and social security454/9€16k€20k▲
Other amounts payable47/48€575k€677k▲
Accrued charges and deferred income492/3€6k€6k▲
Income statement
Code20232024
Remuneration, social security and pensions62€158k€158k▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€7k€5k▼
Other operating charges640/8€2k€1k▼
Gross operating margin9900€336k€268k▼
Operating profit (loss)9901€170k€104k▼
Financial income75/76B€42€48▲
Recurring financial income75€42€48▲
Financial charges65/66B€15k€15k▲
Recurring financial charges65€15k€15k▲
Profit (loss) for the period before taxes9903€156k€89k▼
Income taxes67/77€37k€25k▼
Profit (loss) for the period9904€119k€64k▼
Profit (loss) for the period to be appropriated9905€119k€64k▼
Appropriation of the result
Profit (loss) to be appropriated9906€119k€64k▼
Transfer to equity691/2€119k€64k▼
To other reserves6921€119k€64k▼
Social balance
Average headcount (FTE)90872.32.3=
The notes to these accounts (9 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
2025
31-08
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema · 31 days late
2024
26-08
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema · 26 days late
2023
31-12
Financial
Equity above €500kEq €608k ▲24.2%
6 profitable years in a row build equity to €608k.
27-07
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
29-07
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
26-08
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema · 26 days late
2020
31-12
Financial
Weakest financial yearnet €1k ▼98.4%
Net result drops to €1k, the lowest in the series; recovery starts the following year.
30-08
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema · 30 days late
2019
06-06
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema
2018
17-07
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema
2017
26-07
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Leuven · 1 establishment unit since 2015
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Vaartdijk 113018 LeuvenGround area
347 m²
Building footprint
347 m²
Volume, LiDAR
3,067 m³
Parcel 24038C0171/00M007, Flanders · tallest building 10.4 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
Leuven Pharma Services
since 20152.252.109.673
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 24038C0171/00M007 | Flanders | 347 m² | 1 · 347 m² | 10.4 m · 3 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
SBQ Invest
BE 0650.761.221
Lint · Eq €672k
EUFIPAR
BE 0456.375.102
Elsene · Eq €672k
Management SIEM
BE 0627.763.016
Scherpenheuvel-Zichem · Eq €672k
LA CLICHERIE BRUXELLOISE
BE 0535.976.864
Anderlecht · Eq €672k
KvdKONSULTING
BE 0884.836.968
Poperinge · Eq €673k
Of 24,728 companies in sector 64210 we hold annual accounts for 19,760. 13,359 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded04-12-2015
Fiscal year end31-12
Abbreviation NL
LPS
Activities, NACEBEL
47730Retail sale of pharmaceutical products
64200Holdings
64210Activities of holding companies
Sources
Crossroads Bank for EnterprisesNational Bank · 9 filingsAddress and cadastre registers
Data from official sources, last processed on 20-09-2026. Scores and ratios are computed by Checked and are not a credit decision.